Xia, Yong-Xiang

Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice. [electronic resource] - Hepatobiliary & pancreatic diseases international : HBPD INT Jun 2012 - 278-84 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1499-3872

10.1016/s1499-3872(12)60161-1 doi


Alanine Transaminase--blood
Animals
Apoptosis--drug effects
Axin Protein--metabolism
Blotting, Western
Cell Proliferation--drug effects
Cyclin D1--metabolism
Disease Models, Animal
Gene Expression Regulation
Glycogen Synthase Kinase 3--antagonists & inhibitors
Glycogen Synthase Kinase 3 beta
Immunohistochemistry
Indoles--pharmacology
Inhibitor of Apoptosis Proteins--metabolism
Liver--blood supply
Liver Regeneration--drug effects
Male
Maleimides--pharmacology
Mice
Mice, Inbred C57BL
Phosphorylation
Protein Kinase Inhibitors--pharmacology
Proto-Oncogene Proteins--metabolism
Proto-Oncogene Proteins c-bcl-2
Real-Time Polymerase Chain Reaction
Reperfusion Injury--enzymology
Repressor Proteins--metabolism
Signal Transduction--drug effects
Survivin
Time Factors
beta Catenin--metabolism